IL-21 R

IL-21 R

IL-21 R Informations sur la molécule

Molecule Name
Interleukin 21 Receptor
Alias de la molécule
IL21R,CD360,NILR
Drug Development Progress
Nombre de médicaments cliniques2
Nombre de médicaments commercialisés0
Phase de R&D la plus avancéePhase 1 Clinical
Alias de la cible
UNQ3121/PRO10273,Interleukin-21 receptor,IL21R,IL-21R,Interleukin 21 Receptor,Novel Interleukin Receptor,IL-21 Receptor,NILR,CD360 Antigen,CD360,IMD56,Receptors, Interleukin-21
Contexte de la molécule
Interleukin-21 receptor (IL21R) is also known as CD antigen CD360, Novel interleukin receptor (NILR), is a receptor for interleukin-21 and belongs to the type I cytokine receptor family or type 4 subfamily. IL21R contains two fibronectin type-III domains. IL21R is selectively expressed in lymphoid tissues and most highly expressed in thymus and spleen. IL21R transduces the growth promoting signal of IL21, and is important for the proliferation and differentiation of T cells, B cells, and natural killer (NK) cells.

IL-21 R Liste de produits

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
JS-014Exenokine-21; JS-014; AWT-008Phase 1 ClinicalAnwita Biosciences Inc
Carcinoma, Hepatocellular; Lymphoma; Neoplasms; Solid tumours
Details
LatikafuspAMG-256Phase 1 ClinicalAmgen Inc
Solid tumours
Details